| Sunday, 27 April 2008 |
| 11.00 |
Opening remarks
|
| 11.10 |
Biotechnology: The Future of Medicine
• Introduction of Biotech Industry
• Biotech Medicines
• What are Biosimilars?
• Biotechnology uses in healthcare
Tom Bols Director Government Affairs, Europe
Amgen International
|
| 12.10 |
Bioethical Issues and the
Middle East
•Introduction of Bioethics
•Compelling Issues: Genetics, Pharmacovigilence & Clinical Trials
•Middle Eastern Relevancy of Global Standards
Colleen Lyons, MBe, Principal
The Lyons Trust
|
| 13.10 |
Current Trends in Molecular Biotechnology
• Historical description of biotechnology methods
• Recent discoveries in genomic
• How to transfer molecular biotechnology to developing countries
Afif Abdel Nour, PhD, Research Scientist, Molecular Biotechnology
Institut Polytechnique LaSalle Beauvais
|
| 14.10 |
Genetics and Personalized Medicine: The Future is Now?
• Latest advances in personalized medicine
• Future uses of genetic for personalized medicine
Dr. Erol Baysal, FRCP (London)
Consultant Molecular Geneticist, Head of Molecular Genetics Unit, Senior Lecturer
Dubai Genetic & Thalassemia Center, Al Wasl Hospital
|
| 15.00 |
Close
|
Monday, 28 April 2008
|
| 11.00 |
Opening remarks
|
| 11.10 |
Bridging the Gap: From Doctor to Clinical Investigator
• Trends in clinical investigator doctors
• How to become an investigator
Ghassan Ahmed, MD, CCRA
Secretary/Treasurer, Association of Clinical Research Professionals
|
| 12.10 |
A to Z: Tips on How to Develop a Clinical Trial
• Essential clinical trials documents and materials
• How to write a clinical study protocol
• Ethical considerations: The declaration of Helsinki
• Current compliance concerns (FDA)
Maha Al-Farhan, M.Phil, M.B.A, CCRA
Managing Director, Middle East Clinical Research Organization
|
| 13:10 |
Clinical trial application processes followed around the world
• Review of the processes followed to review CTAs globally
• Time taken for clinical trials to be approved in the various countries
• Suitability of the various processes for a country with an emerging clinical trial industry
• Regulatory implications of changing paradigms in drug development
• Need for flexibility to enable a balance between rigorous regulatory authority oversight and efficient drug development
Lynn Katsoulis, PhD, RAC
Associate Director Drug Development, Cato Research
|
| 14.10 |
Panel Discussion: The Future of Clinical Trials in Middle East
Vladimir Misik, PhD
Regional Sr Director Middle East, Quintiles Eastern Holdings GesmbH
Maha Al-Farhan, M.Phil, M.B.A, CCRA
Managing Director, Middle East Clinical Research Organization
|
15.00
|
Close
|
Tuesday, 29 April 2008
|
| 11.00 |
Opening remarks
|
| 11.10 |
Latest Advances in Pharmaceutical Biotechnology
• Background on pharmaceutical biotechnology
• Biotechnology applications in the various scientific fields
G. Garrett Vygantas, M.D.
Burrill & Company
|
| 12.10 |
The Latest Developments and the Future Aspects of IVF
• New developments and procedures in IVF
• Induction-ovulation protocols
• Achieving higher pregnancies rate policies
• In Vitro-Maturation of Human Oocytes
• Preimplantation Genetic Diagnosis
• Stem Cell Research in fertility
Dr Suleiman Dabit
Head of ART & Genetic dpt
Al/Khalidi Medical Center
|
| 13.10 |
Managing High Alert Medications: The Tawam Hospital Experience
Hashem A Tarifi, MS.,Ph.D.,MBA.,FASHP
Head of Pharmacy, Tawam Hospital in affiliation with Johns Hopkins Medicine
|
| |
|
| 14.10 |
Trends in Oncology Pharmacy
• Overview of Cancer Epidemiology
• Latest Trends in Oncology Pharmacy
• Issues related to Oncology Pharmacy
Wendy Wong, PharmD
University of California-Irvine Medical Center
|
| 15.00 |
Close
|
| Back to Conference Programmes |